載入中
NYSEHealthcareMedical - Healthcare Information Services
最新資料
US$10.81
+US$0.15 · +1.41%
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
前收盤價
US$10.81
+US$0.15 · +1.41%
盤中時間採用ET。市場資料可能有所延遲。
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
日內區間
目前US$10.81
52週區間
目前US$10.81
盤中時間採用ET。市場資料可能有所延遲。
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
日內區間
目前US$10.81
52週區間
目前US$10.81
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 4.81億 USD | 4.2億 USD | 3.56億 USD | 2.81億 USD | 2.13億 USD |
| 銷貨成本 | 1.54億 USD | 1.35億 USD | 1.24億 USD | 1.09億 USD | 8138.8萬 USD |
| 毛利 | 3.26億 USD | 2.85億 USD | 2.32億 USD | 1.72億 USD | 1.32億 USD |
| 研究與開發 | 1.21億 USD | 1.17億 USD | 1.12億 USD | 9124.4萬 USD | 5226.5萬 USD |
| 銷售、一般及管理費用 | 1.8億 USD | 1.98億 USD | 2.27億 USD | 2.32億 USD | 1.75億 USD |
| 營業費用 | 3.33億 USD | 3.43億 USD | 3.69億 USD | 3.48億 USD | 2.49億 USD |
| 利息收入 | 217.3萬 USD | 267.7萬 USD | 406.5萬 USD | 247.5萬 USD | 7.9萬 USD |
| 利息支出 | 695.3萬 USD | 234.7萬 USD | 185.4萬 USD | 141.1萬 USD | 116.3萬 USD |
| 折舊和攤銷 | 3145.3萬 USD | 2788.6萬 USD | 2948.7萬 USD | 2530.4萬 USD | 2451.7萬 USD |
| 營業利益 | −661.2萬 USD | −5809.7萬 USD | −1.36億 USD | −1.77億 USD | −1.17億 USD |
| 淨利 | 230.6萬 USD | −5852.7萬 USD | −1.37億 USD | −1.76億 USD | −1.18億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$12.00
上漲空間 11.01%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2242.78萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1439.64萬0.02%787.4億 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF823.29萬0.01%954億 USD0.05%US$235+0.80%
Fidelity Enhanced Small Cap ETFFESM548.29萬0.08%64.1億 USD0.28%US$45.46+0.46%
iShares Russell 2000 Growth ETFIWO423.76萬0.03%139.17億 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO348.66萬0.02%180億 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA278.95萬0.01%218.24億 USD0.03%US$32.79+0.40%
Principal U.S. Small-Cap Multi-Factor ETFPSC245.05萬0.09%27億 USD0.38%US$67.70+0.61%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAPrincipal U.S. Small-Cap Multi-Factor ETFPSCAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
